A woman undergoing IVF treatment in Germany has reported experiencing spotting, or *Schmierblutung* in German, while taking Clexane, a blood thinner, during the ninth week of her pregnancy. The patient, who initiated the IVF process, reported the bleeding developed this evening, according to a post on the Urbia.de online forum.
Clexane, also known as enoxaparin, is frequently prescribed during pregnancy for women with an increased risk of blood clots, including those with a history of thrombosis, genetic predispositions, or underlying conditions like diabetes or hypertension, according to information from heb-franziska-zedler.de.
The woman’s post prompted responses from other users who shared their experiences. One user reported having received two Clexane injections during the first trimester without experiencing any spotting, and continued to take another heparin, Innohep, throughout her pregnancy without bleeding, currently being in her 40th week. Another user suggested consulting a doctor about progesteron supplementation and magnesium intake, noting that spotting is common in early pregnancy and a definitive diagnosis at five weeks is often tricky.
Spotting occurs in approximately one in four pregnancies during the early stages, according to a post on kinderwunschforum.com. The forum post states that such bleeding is often difficult to prevent or effectively treat.
One user on Rund-ums-Baby.de cautioned that a single instance of minimal bleeding without accompanying abdominal pain may be benign, but requires medical evaluation to determine the cause. Another user, posting on the same forum, described experiencing a small bleed at 4+1 weeks of pregnancy and receiving progesteron from her gynecologist as a precautionary measure.
The original poster indicated she had previously paused Clexane and Ass (acetylsalicylic acid) after experiencing earlier, resolved bleeding at 6+0 weeks. She is currently taking Famenita, Prolutex, and Progynova, and had recently increased her dosages of Famenita and Progynova prior to the onset of the current spotting. An ultrasound examination is scheduled for September 16th, according to the original post.
